THRX may trend higher into Jan, but the risk reward is not in it for me with the large number of other biotech stocks starting to move move up. I play tax selling plays this time of the year, stocks that have been killed with likely moves of over 100% into Jan, THRX doesn't fit that line of thinking for me....